Samdal H H, Gutigard B G, Labay D, Wiik S I, Skaug K, Skar A G
Department of Virology, National Institute of Public Health, Oslo, Norway.
Clin Diagn Virol. 1996 Oct;7(1):55-61. doi: 10.1016/s0928-0197(96)00244-9.
To compare the sensitivity of four rapid assays for the detection of antibodies against HIV-1 during early seroconversion.
Four rapid assays for the detection of antibodies to HIV-1/HIV-2 (SUDS HIV 1 + 2, TestPack HIV-1/HIV-2, HIV-SPOT and CAPILLUS HIV-1/HIV-2) were evaluated on 38 sera derived from 14 HIV-1 seroconverters, formerly tested with Abbott second- and third-generation HIV-1/HIV-2 enzyme immunoassay (EIA) and Diagnostic Biotechnology HIV blot 2.2. EIA-negative sera had also been investigated by HIV-1 antigen testing and polymerase chain reaction (PCR) analysis detecting HIV-1 proviral DNA.
On 16 sera which were Abbott second-generation EIA negative, the SUDS assay rated highest with six positive results. Four sera were TestPack positive. No specimens in this group were HIV-SPOT positive or CAPILLUS positive. Of the remaining 22 sera (Abbott second- and third-generation EIA positive), all but two were positive in all tests.
The study revealed differences in the sensitivities of the rapid assays in the early phase of seroconversion. The most sensitive assay, SUDS, was even more sensitive than the Abbott third-generation EIA, while TestPack and the EIA were equally sensitive. Based on these findings, we suggest the inclusion of these assays in the supplemental testing for detection of antibodies to HIV.
比较四种快速检测法在HIV-1早期血清转化期间检测抗HIV-1抗体的敏感性。
对来自14名HIV-1血清转化者的38份血清进行了四种检测HIV-1/HIV-2抗体的快速检测法(SUDS HIV 1 + 2、TestPack HIV-1/HIV-2、HIV-SPOT和CAPILLUS HIV-1/HIV-2)评估,这些血清先前已用雅培第二代和第三代HIV-1/HIV-2酶免疫测定(EIA)以及诊断生物技术HIV印迹2.2进行检测。EIA阴性的血清也通过HIV-1抗原检测和检测HIV-1前病毒DNA的聚合酶链反应(PCR)分析进行了研究。
在16份雅培第二代EIA阴性的血清中,SUDS检测法阳性结果最多,有6份呈阳性。4份血清TestPack检测呈阳性。该组中没有标本HIV-SPOT检测呈阳性或CAPILLUS检测呈阳性。在其余22份血清(雅培第二代和第三代EIA阳性)中,除两份外,所有血清在所有检测中均呈阳性。
该研究揭示了快速检测法在血清转化早期阶段敏感性的差异。最敏感的检测法SUDS甚至比雅培第三代EIA更敏感,而TestPack和EIA的敏感性相同。基于这些发现,我们建议将这些检测法纳入HIV抗体检测的补充检测中。